Clinical update: ATAGI statement on 2018 seasonal influenza vaccines

The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice to support immunisation providers ahead of this year's influenza season. 

The ATAGI advice indicates:

• annual vaccination is the most important measure to prevent influenza and its complications
• annual influenza vaccination is recommended for all persons 6 months of age and over
• for adults aged 65 years and over, two higher-immunogenicity trivalent influenza vaccine (TIV) formulations (one a 'high-dose' vaccine and another containing an adjuvant) are available and National Immunisation Program funded
• quadrivalent influenza vaccines (QIVs) continue to be clinically recommended for those under the age of 65 years.

Please see ATAGI's clinical advice on 2018 seasonal influenza vaccines in full.